Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +13.00p +0.64% 2,047.00p 2,041.00p 2,043.00p 2,050.00p 2,023.00p 2,033.00p 337,936.00 16:35:09
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 977.3 215.8 85.9 20.2 4,912.21

Hikma Pharmaceuticals Share Discussion Threads

Showing 501 to 525 of 525 messages
Chat Pages: 21  20  19  18  17  16  15  14  13  12  11  10  Older
DateSubjectAuthorDiscuss
21/2/2017
18:57
One step at a time. Let's break through £20.60 first then £21.
karateboy
21/2/2017
15:27
Still looking positive. British Bulls:- HIKMA PHARMACEUTICALS Last Signal:STAY LONG Our system’s recommendation today is to STAY LONG. The previous BUY signal was issued on 01/02/2017, 19 days ago, when the stock price was 1,848.0000. Since then HIK.L has risen by +10.06%. Financial Times As of Feb 18, 2017, the consensus forecast amongst 12 polled investment analysts covering Hikma Pharmaceuticals Plc advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Jun 30, 2016. The previous consensus forecast advised investors to purchase equity in Hikma Pharmaceuticals Plc. Broker Forecasts - January 2017 Peel Hunt 25/01 Initiates/starts Buy 2,340.00p JP Morgan Cazenove 17/01 Reiterates Overweight 2,100.00p
fez77
17/2/2017
13:33
Indeed, as happened, and now onwards.................... I will be continuing to hold at present since there is still plenty of potential in my opinion.
fez77
16/2/2017
08:15
I expect £20 threshold to be broken today.
karateboy
13/2/2017
20:11
No shorting here - just following the Directors faith in the company. Also The Capital Group Companies, have gone above 10% ownership threshold. These are all good signs as is the Easyhaler deal just signed with Orion.
fez77
13/2/2017
10:07
Good news and time to move up.
karateboy
09/2/2017
17:00
Haha! Is that a deliberate ploy to tempt fate? Have you shorted them? G2theary made a similar comment a couple of weeks back - right before they fell to 1800! Fingers crossed!
shardview
09/2/2017
16:37
Nice healthy rise today. Well on course for the 2,000 level!
fez77
01/2/2017
05:42
trump statement on big pharm was yesterday's big news.
r ball
31/1/2017
20:34
West-Ward Columbus announced the addition of 95 jobs by 2020 to staff an expansion of its pharmaceutical manufacturing facility as well as a warehouse under construction in Obetz, Ohio, according to an article in Columbus Business First.The expansion is for additions to the company's line of generic drugs made at the division of Hikma Pharmaceuticals Plc. Hikma is continuing plans for growth made under former owner Boehringer Ingelheim, the story said.About 65 added technician jobs are expected by the end of 2020 to staff a 30,300-square-foot, two-story addition to the west Columbus plant. West-Ward also is building a 276,000-square-foot distribution facility in Obetz that will create another 30 jobs, according to the article.
coppertrader
31/1/2017
18:37
Some large buys today:- 16:35 - 31/01 Buy 343782 1,824.00p £6,270,583.68 13:19 - 31/01 Buy 151325 1,809.00p £2,737,469.25 13:19 - 31/01 Buy 151000 1,809.00p £2,731,590.00 Keep the faith!
fez77
30/1/2017
20:40
Yes, I wonder who was selling. We'll see how it goes tomorrow.
fez77
30/1/2017
16:56
Picked up a few just before close, bit of blind optimism that the sell-off may have run its course. Then 2 massive sales go through after close! Not looking good for the morning. I still think there's value in these, but the magic 2000 seems a way off right now - to think it seemed a certainty just over a week ago. Just hope they don't edge 16/1700.
shardview
29/1/2017
22:17
Agreed. Its not a share for widows and orphans!
fez77
29/1/2017
14:08
thanks for that up date interesting will hold for the next few months see how it goes but this is a roller coaster of a share. Still in the top 100 so that helps as well Most of the brokers have this as a buy as well and given the large take over a year ago should see some good news flow but can never tell with this share. My only share in this sector
mrthomas
28/1/2017
11:14
No idea when next trading statement will be but full years figures should be available in March. Darhold appears to be a vehicle for Directors etc to hold shares in Hikma. An old Guardian article (May 2015)at https://www.theguardian.com/business/marketforceslive/2015/may/11/hikma-higher-on-buy-note-and-acquisition-prospects included the quote:- "The Jordanian-based company has expanded rapidly over the past few years by building a world-class injectable generics business and enjoyed strong growth as a branded pharma player in its home MENA markets. Following the recent decline in Hikma’s share price, the company now trades at a 10% 2015 PER discount to its peers. We believe the sell-off is overdone, and we are therefore upgrading our recommendation to Buy. Any reticence to consider Hikma seems to primarily be concerned with Hikma’s roots as a Jordanian, family-run company with a large operation in the Middle East. However, with the family controlling 28.8% of the company through their Darhold Ltd stake, management interests are well aligned with the shareholders. We believe large acquisitions are possible in the near future and will remain an integral part of Hikma’s business plan...." As I said before, it is a bumpy ride, but one where the largest shareholders are prepared to put their money where their mouth is!
fez77
27/1/2017
11:03
I had this share last year and sold at a profit but not before it gone up 50% then down again. Any idea when the next trading statement is as the last two have not been kind to the shares. Sorry who Darhold do they hold 25% of the comany and who behind them thanks If could get past 20 that be good
mrthomas
26/1/2017
12:43
This is a bit of a bumpy ride, but latest broker forecast (Peel Hunt) on 25 January has an assessment of "Buy" with a target of 2340. I'll be in to at least 2000 and hopefully higher. This will move very quickly if there is further good news or renewed massive purchases from Darhold Limited who already own over 25%.
fez77
23/1/2017
21:33
Pharma with generic medicines should do better in Trump world as their medicines are cheaper.
karateboy
23/1/2017
15:07
Shardview - It's up to you to take a profit if you wish. I'm going to be holding at present and seeking a level of 2,000.
fez77
23/1/2017
11:54
Anyone getting a bit nervous that, at least in the short/medium term, these may have peaked? They're some distance from their 1575 floor and there seems to be a fair bit of negativity around pharma at present.
shardview
20/1/2017
22:16
Nice.......I suspect its DARHOLD LTD again!!!!
fez77
20/1/2017
21:54
145000 buy with a premium at close.
karateboy
18/1/2017
09:43
News - 18 January - Hikma receives approval for Sodium Oxybate Oral Solution London, 18 January 2017 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announces that its wholly owned US subsidiary, Roxane Laboratories, Inc. (Roxane), has received an approval from the US Food and Drug Administration for its Sodium Oxybate Oral Solution, 500 mg/mL, the generic equivalent to Xyrem®. Roxane's Sodium Oxybate Oral Solution is indicated for the treatment of cataplexy (sudden loss of muscle strength) and excessive daytime sleepiness in patients with narcolepsy.
fez77
18/1/2017
09:34
4217 shares. Going nicely today........
fez77
Chat Pages: 21  20  19  18  17  16  15  14  13  12  11  10  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170221 21:13:44